With over 25 years of operations experience in the biotech and pharma industry, I am a visionary leader who drives strategic vision and growth for innovative companies. As the Chairman and CEO of TNA Therapeutics, a clinical-stage pharma company, I am responsible for leading the development of our novel therapies for rare oncological and immunological diseases, as well as leading all operations; capital raising, M&A, clinical and scaling for planned growth.My leadership success is built on the world-class influences and training I have had in some of the top U.S. and global companies, and academic and research institutions, where I gained valuable experience in P&L management, R&D portfolio management, clinical operations, business development, compliance and regulatory affairs, and board governance. I have a proven track record; raising over $50M in capital, managing a budget of over $650M and a team of over 250 FTEs, and establishing strategic partnerships and alliances with key stakeholders and industry contacts worldwide. I am passionate about building and mentoring high-potential teams, empowering them to bring forward new ideas and solutions that enhance our performance and value proposition.
Listed skills include Clinical Trials, Medical Writing, Ich Gcp, Life Cycle Manager Skilled In Cro/Vendor Qualification, and 48 others.